Title,Session ID,SessionLoc,Session Type,Session URL
ADT02. Designing the Next Generation of Antibody Drug Conjugates,74,Room 30 - Upper Level - Convention Center,Advances in Diagnostics and Therapeutics,https://www.abstractsonline.com/pp8/#!/20272/session/74
ADT03. Ex Vivo Functional Diagnostics for Cancer Precision Medicine,76,Room 6 DE - Upper Level - Convention Center,Advances in Diagnostics and Therapeutics,https://www.abstractsonline.com/pp8/#!/20272/session/76
ADT08. Oligometastasis: Curable Metastatic State?,108,Room 28 - Upper Level - Convention Center,Advances in Diagnostics and Therapeutics,https://www.abstractsonline.com/pp8/#!/20272/session/108
ADT01. No Time to Waste: Understanding and Addressing Cancer Cachexia,73,Room 16 - Mezzanine Level - Convention Center,Advances in Diagnostics and Therapeutics,https://www.abstractsonline.com/pp8/#!/20272/session/73
ADT05. Chemical Biology Approaches to Tackle Undruggable Targets,94,Room 29 - Upper Level - Convention Center,Advances in Diagnostics and Therapeutics,https://www.abstractsonline.com/pp8/#!/20272/session/94
ADT04. Drugging Transcription Factors,92,Room 29 - Upper Level - Convention Center,Advances in Diagnostics and Therapeutics,https://www.abstractsonline.com/pp8/#!/20272/session/92
ADT07. Radiotheranostics: A Paradigm-Shifting Therapy,107,Room 11 - Upper Level - Convention Center,Advances in Diagnostics and Therapeutics,https://www.abstractsonline.com/pp8/#!/20272/session/107
ADT06. KRAS: Broadening the Attack Beyond G12C with Small Molecules and Immuno-Oncology,104,Ballroom 20 AB - Upper Level - Convention Center,Advances in Diagnostics and Therapeutics,https://www.abstractsonline.com/pp8/#!/20272/session/104
ADT09. Advances in T-cell Bispecific Approaches Targeting Solid Tumors,109,Room 6 CF - Upper Level - Convention Center,Advances in Diagnostics and Therapeutics,https://www.abstractsonline.com/pp8/#!/20272/session/109
AHM01. Precursors to Hematologic Malignancies,110,Room 15 - Mezzanine Level - Convention Center,Advances in Hematologic Malignancies,https://www.abstractsonline.com/pp8/#!/20272/session/110
AHM06. Relapse after Allogeneic Bone Marrow Transplant,115,Room 15 - Mezzanine Level - Convention Center,Advances in Hematologic Malignancies,https://www.abstractsonline.com/pp8/#!/20272/session/115
AHM04. Ongoing Advances in the Understanding and Treatment of Acute Myeloid Leukemia,113,Room 14 - Mezzanine Level - Convention Center,Advances in Hematologic Malignancies,https://www.abstractsonline.com/pp8/#!/20272/session/113
AHM02. Immune Microenvironment in Hematologic Malignancies ,111,Room 15 - Mezzanine Level - Convention Center,Advances in Hematologic Malignancies,https://www.abstractsonline.com/pp8/#!/20272/session/111
AHM05. Advances in Lymphoma,114,Room 14 - Mezzanine Level - Convention Center,Advances in Hematologic Malignancies,https://www.abstractsonline.com/pp8/#!/20272/session/114
AHM03. Understanding the Mechanisms of Resistance to Immunotherapeutic Approaches in Multiple Myeloma,112,Room 33 - Upper Level - Convention Center,Advances in Hematologic Malignancies,https://www.abstractsonline.com/pp8/#!/20272/session/112
AOS01. Inflammatory Breast Cancer,116,Room 16 - Mezzanine Level - Convention Center,Advances in Organ Site Research,https://www.abstractsonline.com/pp8/#!/20272/session/116
AOS05. Novel Strategies for Early Detection of Ovarian Cancer,120,Room 17 - Mezzanine Level - Convention Center,Advances in Organ Site Research,https://www.abstractsonline.com/pp8/#!/20272/session/120
AOS03. Emerging Non-invasive Tests for Colorectal Cancer Screening: Potential Opportunities and Pitfalls,118,Room 14 - Mezzanine Level - Convention Center,Advances in Organ Site Research,https://www.abstractsonline.com/pp8/#!/20272/session/118
AOS02. Advances and Challenges in Therapy for Malignant Glioma,117,Room 15 - Mezzanine Level - Convention Center,Advances in Organ Site Research,https://www.abstractsonline.com/pp8/#!/20272/session/117
AOS08. Translational and Clinical Advances in Pancreatic Cancer,123,Ballroom 6 A - Upper Level - Convention Center,Advances in Organ Site Research,https://www.abstractsonline.com/pp8/#!/20272/session/123
AOS06. Impact of Tumor Heterogeneity on the Evolution of Pancreatic Cancer,121,Room 6 CF - Upper Level - Convention Center,Advances in Organ Site Research,https://www.abstractsonline.com/pp8/#!/20272/session/121
AOS09. Uveal Melanoma: Elucidating the Adjuvant Window of Therapeutic Opportunity,124,Room 17 - Mezzanine Level - Convention Center,Advances in Organ Site Research,https://www.abstractsonline.com/pp8/#!/20272/session/124
AOS11. Updates from SABCS 2023,563,Room 28 - Upper Level - Convention Center,Advances in Organ Site Research,https://www.abstractsonline.com/pp8/#!/20272/session/563
AOS10. Dharma Master Jiantai Advances in Lung Cancer Research Session: Deciphering Lung Cancer in Non-smokers - Dedicated to the Memory of Richard H. Creech,125,Ballroom 6 A - Upper Level - Convention Center,Advances in Organ Site Research,https://www.abstractsonline.com/pp8/#!/20272/session/125
AOS07. Androgen Receptor as a Pro-Differentiation and Oncogenic Transcription Factor in Prostate Cancer,122,Room 15 - Mezzanine Level - Convention Center,Advances in Organ Site Research,https://www.abstractsonline.com/pp8/#!/20272/session/122
CTMS01. Cancer Vaccines: Ready for Prime Time?,663,Ballroom 20 AB - Upper Level - Convention Center,Clinical Trials Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/663
CTMS02. Advances in Immunotherapy,664,Hall GH - Ground Level - Convention Center,Clinical Trials Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/664
CTMS03. Novel Agents and Emerging Therapeutic Strategies,665,Hall GH - Ground Level - Convention Center,Clinical Trials Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/665
CTPL01. Beyond Immune Checkpoint Inhibition: Novel Immunotherapy Strategies,659,Hall GH - Ground Level - Convention Center,Clinical Trials Plenary Session,https://www.abstractsonline.com/pp8/#!/20272/session/659
CTPL02. Novel Immune Checkpoint Inhibitor Combinations,660,Hall GH - Ground Level - Convention Center,Clinical Trials Plenary Session,https://www.abstractsonline.com/pp8/#!/20272/session/660
CTPL03. Advances in Targeted Therapy,661,Ballroom 20 AB - Upper Level - Convention Center,Clinical Trials Plenary Session,https://www.abstractsonline.com/pp8/#!/20272/session/661
CTPL04. Biomarkers: Quantifying Pharmacodynamic Modulation,662,Hall GH - Ground Level - Convention Center,Clinical Trials Plenary Session,https://www.abstractsonline.com/pp8/#!/20272/session/662
ED02. Are You Targeting Your Protein?,470,Room 28 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/470
ED09. Integrating Evolutionary Principles into Clinical Trial Design and Analysis,482,Room 6 CF - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/482
ED12. Measuring Structural and Social Determinants of Health in Cancer Research,485,Room 6 DE - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/485
"ED22. Determinants and Meanings of T Cell Recognition, Exhaustion, and Persistence",523,Ballroom 20 AB - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/523
ED33. What is the State of the Art in Functional Precision Medicine?,535,Ballroom 20 CD - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/535
ED43. Models to Study the Tumor Microenvironment Accounting for Cancer Health Disparities,511,Ballroom 6 B - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/511
ED50. Evolving Insights on the Microbiome in Cancer,504,Room 30 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/504
ED04. Chemistry to the Clinic Part 1 of 3: Targeted Protein Degraders: Delivering Degraders to the Site of Action,474,Ballroom 6 B - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/474
ED27. Implementing Alternative Manufacturing and Delivery Models to Improve Access to CAR-T Therapy,528,Ballroom 20 AB - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/528
ED37. A Systems Approach to Cancer Early Detection,517,Ballroom 6 A - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/517
ED46. Organoid Models of Human Cancer Evolution,508,Ballroom 20 CD - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/508
ED01. Data Science Opportunities and Challenges in Biomarker-based Early Detection of Cancer,468,Room 6 CF - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/468
ED03. Chemo-proteomics Approaches in Drug Discovery,473,Room 31 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/473
ED19. Illuminating the Genomic “Dark Matter” in Cancer: The Role of Non-Coding Elements in Cancer and Aging,520,Room 30 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/520
ED21. A Decade of Cancer Vaccines: Dedicated to the Memory of Harald zur Hausen,522,Ballroom 20 CD - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/522
ED25. Beyond CD8 T Cells: Targeting CD4 T Cells in Cancer,526,Ballroom 20 AB - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/526
ED32. Existing and Emerging Cohort Study Resources for Future Discoveries,534,Room 11 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/534
ED35. Development and Evaluation of Drug Response Predictors for Precision Oncology,537,Ballroom 6 A - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/537
ED38. Gene-Environment Interactions Driving Carcinogenesis,516,Room 33 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/516
ED40. Theranostics: The Nuts and Bolts,514,Room 6 DE - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/514
ED47. Lineage Plasticity in Tumor Evolution and Acquired Resistance,507,Ballroom 6 B - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/507
ED53. Team Science: How to Form and Manage a Multidisciplinary Cancer Research Team,666,Room 5 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/666
DC01. Navigating Laboratory Developed Tests in Oncology: Emerging Needs and Opportunities,44,Room 1 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/44
ED08. Stressing Out About Treatment Resistance: Progress and Challenges,481,Ballroom 6 B - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/481
ED11. Race and Genetic Ancestry in Research: Leveraging Value While Avoiding Harms,484,Room 6 DE - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/484
ED15. Entrepreneurship: Interacting with Regulatory Agencies,488,Room 5 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/488
ED24. Tumor Immunology and Immunotherapy for Non-Immunologists Session: Strategies for Enhancing Adoptive Cellular Immunotherapy and Reprogramming the Tumor Microenvironment,525,Ballroom 20 CD - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/525
ED28. The Emerging Role of Liquid Biopsies in the Cancer Care Continuum,530,Ballroom 20 AB - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/530
ED29. The Reimagined Cell Cycle in 2024: Implications for Cancer,531,Room 6 CF - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/531
ED42. Understanding and Improving Replicability in Cancer Biology,512,Room 30 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/512
ED44. Host Predisposing Stroma in Cancer Development and Progression,510,Ballroom 6 A - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/510
DC06. Rethinking Risk and Risk Assessment for Liquid Biopsy-Based Single- and Multi-Cancer Screening,49,Room 1 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/49
ED05. Chemistry to the Clinic Part 2 of 3: Considerations in the Discovery of Small Molecules Targeting RNA,476,Room 6 CF - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/476
ED14. The Road to Entrepreneurship,487,Room 5 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/487
ED16. Roles for Genomic Repeats and Transposable Elements in Tumor Biology and Implications for Therapy.,489,Room 2 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/489
"ED18. Germline Genetic Testing in Cancer: Who, What and When?",519,Room 33 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/519
ED23. The Good and the Bad of Myeloid Cells in Cancer,524,Ballroom 6 B - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/524
ED34. Dissecting the Landscape of Genotype-Matched Precision Oncology:  Preclinical and Clinical Applications,536,Room 29 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/536
ED36. Therapeutic and Surgical De-escalation Studies: The Next Challenge in Precision Oncology,518,Ballroom 20 AB - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/518
ED48. &nbsp; Metabolic Dependencies and Adaptations in Cancer,506,Room 31 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/506
ED49. Clonal Hematopoiesis: Translational and Clinical Updates and Implications ,505,Room 6 DE - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/505
DC02. FDA&rsquo;s Project Endpoint and Overall Survival in Oncology Clinical Trials,45,Room 1 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/45
ED06. Chemistry to the Clinic Part 3 of 3: From Virtual Screening to Generative Design: Digital Approaches in Cancer Drug Discovery,479,Room 6 DE - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/479
ED07. Spontaneous Cancers of Companion Animals as Clinically Relevant Models for Advancing Human Oncology,480,Room 29 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/480
"ED10. Genetic Ancestry, Tumor Subtype and Somatic Genomic Landscape",483,Room 31 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/483
ED13. New Targets and Mechanisms of Synthetic Lethality in Cancer Therapy,486,Room 11 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/486
ED17. How Do Epigenetic Modifiers Shape Immune Responses Against Cancer?,490,Room 6 CF - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/490
ED20. Cell Therapies for Solid Tumors,521,Ballroom 20 CD - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/521
ED26. Targeting Dendritic Cells in Cancer Immunotherapy,527,Ballroom 6 B - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/527
ED39. PSA Reboot: Why Prostate Cancer Screening is Not What it Used to be and How it Has Changed,515,Room 33 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/515
ED41. Impact of Scientific and Technological Advances on Radiation Oncology: Challenges and Opportunities in Patient Care,513,Room 5 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/513
ED45. Cancer Phylogenetics,509,Room 2 - Upper Level - Convention Center,Educational Session,https://www.abstractsonline.com/pp8/#!/20272/session/509
ESP1A. Digital PCR applications for oncology research: methylation analysis and variant detection,565,Spotlight Theater A - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/565
"ESP1B. PDX &ndash; Predictive Tumor Models to Accelerate Your Preclinical Research in Vivo, in Vitro and in Silico (Sponsored by Charles River)",566,Spotlight Theater B - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/566
ESP1C. A New Era of Discovery Power: From comprehensive microenvironment characterization to multiomic liquid biopsy,672,,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/672
"ESP1D. Customer Success in Liquid Biopsy with Complete Workflow Solutions: Pre-analytic Sample Prep, Assay Validation, Concordance Studies and Routine Performance Monitoring",580,Spotlight Theater D - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/580
ESP1E. Discovering novel causes and biomarkers of cancer through high dimensional proteomics within a large-scale prospective cohort,570,Spotlight Theater E - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/570
ESP2D. FcResolv™ NOG: Eliminating Murine Fc Gamma Receptor Interference in Antibody-Based Drug Discovery,574,Spotlight Theater D - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/574
ESP2E. Novel technologies for precision medicine: Agilent Avida targeted sequencing and Claudin 18.2 IHC assay for Transcenta Therapeutics’ Osemitamab program,653,Spotlight Theater E - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/653
ESP3A. The Evolution of a Multi-biomarker Class Approach for Multi-cancer Early Detection Testing,567,Spotlight Theater A - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/567
"ESP3B. AI Powered Precision Oncology: Leveraging Diagnostics, Data and AI to Drive Next-Generation Drug Development",657,Spotlight Theater B - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/657
ESP3C. Amping up Your Predictive Power: How Organoid Models are Leading the Way in Colon and Pancreatic Cancer Precision Medicine Approaches,655,Spotlight Theater C - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/655
ESP3D. Empowering Cancer Research: Liquid Biopsy and Neoantigen Discovery for Cancer Immunotherapy,571,Spotlight Theater D - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/571
ESP3E. From Genomic Insights to Clinical Solutions: The Role of 3D Genomics in Cancer Research and Diagnostics,673,Spotlight Theater E - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/673
ESP4A. Comprehensive somatic variant detection with accurate long- and short-read sequencing,579,Spotlight Theater A - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/579
ESP4B. Accelerating precision oncology research with nanopore sequencing,650,Spotlight Theater B - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/650
"ESP4C. Droplet Digital PCR (ddPCR) Drives Progress in Early Cancer Diagnosis, Personalized Therapy, and MRD",577,Spotlight Theater C - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/577
ESP4D. A New View of Spatial Biology – Using Rapid Multiplexed Tissue Imaging to Personalize Cancer Treatments and Introduce a High-Throughput Whole Slide Modality to Profile the Immune Landscape,578,Spotlight Theater D - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/578
ESP4E. Next-Generation Solutions in Drug Development: How NeoGenomics can streamline translational medicine from discovery to the clinic,652,Spotlight Theater E - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/652
ESP5A. Spatial Biology 2.0: Spatial Insights & Precision Medicine at Unprecedented Scale,581,Spotlight Theater A - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/581
"ESP5B.  A Step Toward Precision Medicine, from Biomarker Discovery to Diagnostics and Minimal Residual Disease",651,Spotlight Theater B - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/651
ESP5C. Bringing Versatility to Spatial Biomarker Detection,569,Spotlight Theater C - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/569
ESP5D. New era in single-cell discovery: Using a single-cell multiomics–based ATAC-seq assay and BD SpectralFX™ Technology image-based sorting to study the interplay between molecular and cellular dynamics in T cell activation,658,Spotlight Theater D - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/658
"ESP5E. Introducing the 6-base genome, use duet evoC to discover multimodal insights from your DNA samples",582,Spotlight Theater E - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/582
ESP6A. Biomarker Solutions for All: Innovative solid tumor MRD detection and Immune Profiling Solutions for Advanced Drug Development,649,Spotlight Theater A - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/649
ESP6B. Highest-Plex Spatial Multi-Omics – Eliminating the Blind Spots in Your Research,562,Spotlight Theater B - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/562
ESP6C. Patterns in patients: Why precision medicine needs multimodal data and AI,584,Spotlight Theater C - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/584
ESP6D. A novel cancer vaccine based on hyaluronic acid nanogel (HANG) with the ability of leading to “cure” in combination with T cell therapy,586,Spotlight Theater D - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/586
ESP6E. Harnessing the Power of Automation:  IDT’s xGen™ kits on the Biomek NGeniuS Next Generation Library Prep System,656,Spotlight Theater E - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/656
ESP7B. Same-section Multiomics with MACSima™ Platform - Diving into Spatial Biology to Advance Cancer Therapy,568,Spotlight Theater B - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/568
ESP7C. Single-Cell Mapping of Lineage and Phenotype in Human Somatic Evolution,654,Spotlight Theater C - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/654
"ESP7D. Presence of myeloid and lymphoid cells are key for translational tumor biology, efficacy and safety assessment in humanized mouse models",587,Spotlight Theater D - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/587
ESP7E. Advances in high sensitivity protein detection from biofluids and the potential in early diagnosis and therapeutic monitoring.,585,Spotlight Theater E - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/585
ESP8A. Proteomics in Cancer Immunotherapy: Biomarker Discovery and Therapeutic Insights,572,Spotlight Theater A - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/572
ESP8B. Adaptive Immune Receptor Profiling for Promising Insights into Potential Therapeutic and Biomarker Targets,583,Spotlight Theater B - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/583
"ESP8C. 3D Nuclear, Cellular, Tissue Imaging and Quantification Techniques",674,Spotlight Theater C - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/674
ESP8D. Pharmacodynamic in vivo Models for the Discovery and Development of Cancer Therapeutics,575,Spotlight Theater D - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/575
ESP8E. In-situ sequencing: enabling spatial biology at scale,576,Spotlight Theater E - Sails Pavilion - Conv Ctr,Exhibitor Spotlight Presentation,https://www.abstractsonline.com/pp8/#!/20272/session/576
LBMS01. Minisymposium: Late-Breaking Research,609,Room 16 - Mezzanine Level - Convention Center,Late-Breaking Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/609
"LBPO.BCS01. Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 1",590,Section 51,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/590
LBPO.CH01. Late-Breaking Research: Chemistry,593,Section 52,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/593
LBPO.ET01. Late-Breaking Research: Experimental and Molecular Therapeutics 1,597,Section 53,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/597
LBPO.IM01. Late-Breaking Research: Immunology 1,601,Section 54,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/601
LBPO.CL01. Late-Breaking Research: Clinical Research 1,594,Section 51,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/594
LBPO.IM02. Late-Breaking Research: Immunology 2,602,Section 52,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/602
LBPO.PS01. Late-Breaking Research: Population Sciences,606,Section 53,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/606
LBPO.ET02. Late-Breaking Research: Experimental and Molecular Therapeutics 2,600,Section 52,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/600
LBPO.MCB01. Late-Breaking Research: Molecular/Cellular Biology and Genetics 1,604,Section 53,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/604
LBPO.TB01. Late-Breaking Research: Tumor Biology 1,607,Section 54,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/607
"LBPO.BCS02. Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 2",591,Section 51,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/591
LBPO.ET03. Late-Breaking Research: Experimental and Molecular Therapeutics 3,599,Section 52,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/599
LBPO.MCB02. Late-Breaking Research: Molecular/Cellular Biology and Genetics 2,605,Section 53,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/605
LBPO.TB02. Late-Breaking Research: Tumor Biology 2,608,Section 54,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/608
LBPO.CL02. Late-Breaking Research: Clinical Research 2,595,Section 51,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/595
LBPO.IM03. Late-Breaking Research: Immunology 3,603,Section 53,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/603
"LBPO.PR01. Late-Breaking Research: Prevention, Early Detection, and Interception",624,Section 54,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/624
"LBPO.BCS03. Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 3",592,Section 51,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/592
LBPO.CL03. Late-Breaking Research: Clinical Research 3,596,Section 52,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/596
LBPO.ET04. Late-Breaking Research: Experimental and Molecular Therapeutics 4,598,Section 54,Late-Breaking Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/598
SY18. Tumor Microbiome,132,Room 28 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/132
SY29. Dharma Master Jiantai Symposium in Biomarkers: Genomics-based Predictive Biomarkers for Radiotherapy and Radioimmunotherapy,143,Room 14 - Mezzanine Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/143
SY35. Cancer Metabolism Across Scales: From Organelles to Organisms,149,Ballroom 6 B - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/149
SY39. Novel Immune Checkpoints: Beyond PD1 and CTLA4,153,Room 6 CF - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/153
"SY45. Engineering Strategies Based on NK, and gd T Cells and Their Receptors, and Macrophages",159,Ballroom 6 A - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/159
OP01. Opening Ceremony,5,Hall GH - Ground Level - Convention Center,Opening Ceremony,https://www.abstractsonline.com/pp8/#!/20272/session/5
PO.BCS01.01. Application of Bioinformatics to Cancer Biology 1,186,Section 36,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/186
PO.BCS01.06. Artificial Intelligence and Machine/Deep Learning 1,193,Section 37,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/193
PO.CH01.06. Basic and Applied Nanotechnology and Therapeutics,210,Section 20,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/210
PO.CL01.01. Diagnostic Biomarkers 1,215,Section 42,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/215
PO.CL01.05. Spatial Proteomics and Transcriptomics,219,Section 46,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/219
PO.CL01.15. Early Detection Biomarkers 1,230,Section 43,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/230
PO.CL01.17. Circulating Nucleic Acids 1,231,Section 40,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/231
PO.CL05.01. Clinical Research in Special Populations,174,Section 41,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/174
PO.CL06.05. Tumor Immune Response 1,241,Section 47,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/241
PO.CL07.01. Pediatric Sarcomas and Other Solid Tumors: Translational,250,Section 44,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/250
PO.CL08.03. Application of Precision Medicine for Cancer Care,256,Section 39,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/256
PO.CL09.01. Radiation Oncology,172,Section 45,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/172
PO.ET01.01. Immunotherapy,272,Section 24,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/272
PO.ET01.07. Mechanisms of Drug Action,278,Section 26,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/278
PO.ET02.06. Tumor Microenvironment,286,Section 29,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/286
PO.ET03.09. Drug Resistance 1: Models,300,Section 22,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/300
"PO.ET05.01. Cell Cycle, Transcription Regulation, and Anticancer Drug Action",302,Section 21,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/302
PO.ET06.01. Identification of Molecular Targets,305,Section 23,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/305
"PO.ET08.01. Radiotherapeutic Combinations, Modifiers, Protectors, Sensitizers, and Molecular Targets",314,Section 28,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/314
PO.ET09.05. Novel Antitumor Agents 2,320,Section 27,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/320
PO.ET09.13. Kinase and Phosphatase Inhibitors 1,328,Section 25,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/328
"PO.IM01.01. Biomarkers, Immune Monitoring, and Immune Assays",332,Section 3,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/332
PO.IM01.13. Adoptive Cell Therapies 1: Tumor Antigen-Specific T-cells and TCR-T,342,Section 1,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/342
PO.IM01.14. Adoptive Cell Therapies 2: CAR-T Cells,345,Section 2,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/345
PO.IM02.07. Tumor-Induced Immune Suppression 1: Extrinsic Factors,358,Section 4,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/358
PO.MCB02.01. Apoptosis and Ferroptosis,176,Section 15,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/176
PO.MCB04.01. Cellular Stress Responses 1,367,Section 16,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/367
PO.MCB05.01. DNA Damage and Repair 1,369,Section 17,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/369
"PO.MCB08.01. Advances in Genomic Sequencing Platforms, Methodologies, and Interpretation 1",381,Section 14,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/381
PO.MCB09.01. Metabolic Pathways 1,388,Section 18,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/388
PO.MCB10.01. microRNAs and Other Non-coding RNAs as Cancer Genes 1,394,Section 19,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/394
PO.PR01.01. Cancer Prevention,401,Section 31,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/401
PO.PR01.03. Epidemiology,403,Section 32,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/403
PO.PS01.02. Cancer Disparities 1: Emerging Trends in Cancer Disparities Research,415,Section 33,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/415
"PO.PS01.10. Environmental and Occupational Risk Factors, Infection, and Aging",422,Section 34,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/422
PO.RSP01.01. Regulatory Science and Policy,179,Section 38,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/179
"PO.TB04.04. Membrane, Biophysical, and EMT Aspects of Motility/Metastasis",428,Section 8,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/428
PO.TB05.04. Organoid Models of Cancer 1,435,Section 9,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/435
PO.TB06.01. Developmental Origins and Drivers of Pediatric Cancer,438,Section 6,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/438
PO.TB08.01. Stem Cells in Tumor Initiation and Progression,445,Section 10,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/445
PO.TB09.01. Tumor Adhesion,185,Section 12,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/185
"PO.TB11.01. Macrophages, Neutrophils, and NK Cells in Cancer",452,Section 7,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/452
PO.TB11.05. Stroma Interactions,455,Section 11,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/455
PO.BCS01.02. Application of Bioinformatics to Cancer Biology 2,189,Section 35,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/189
"PO.BCS01.12. New Algorithms, Software, and Models",547,Section 37,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/547
PO.BCS02.04. Liquid Biopsy and Precision Oncology,202,Section 36,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/202
PO.CH01.02. Lead Identification and Optimization,205,Section 20,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/205
PO.CH02.01. Proteomics and Mass Spectrometry 1,209,Section 21,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/209
PO.CL01.07. Predictive Biomarkers 1,223,Section 43,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/223
PO.CL01.08. Predictive Biomarkers 2,221,Section 44,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/221
PO.CL01.16. Early Detection Biomarkers 2,229,Section 41,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/229
PO.CL01.18. Circulating Nucleic Acids 2,232,Section 40,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/232
PO.CL02.01. Biostatistics in Clinical Trials / Surgical Oncology,173,Section 39,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/173
PO.CL06.07. Antibodies 1,244,Section 38,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/244
PO.CL06.11. Immunomodulatory Interventions and Mechanisms,248,Section 42,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/248
PO.CL10.01. Real-World Biomarkers,258,Section 45,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/258
PO.CL13.02. Translational Research: Imaging and Radiomics,266,Section 46,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/266
PO.CT01.04. Phase I Clinical Trials 1,613,Section 48,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/613
PO.CTP01.01. Phase I Clinical Trials in Progress 1,619,Section 49,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/619
PO.ET01.02. Antibody-Drug Conjugates and Bispectific Antibodies,273,Section 23,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/273
PO.ET02.02. Antibody-Based Technologies and New Inhibitors,282,Section 22,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/282
PO.ET02.07. New Technologies,287,Section 28,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/287
PO.ET03.01. Mechanisms of Drug Resistance 1,290,Section 26,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/290
PO.ET03.04. Drug Resistance 2: Ras GTPase,294,Section 24,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/294
"PO.ET05.02. Microenvironment, Immunity, and DNA Repair in Therapeutic Response",301,Section 27,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/301
PO.ET07.02. Pharmacodynamic Biomarkers of Drug Response,311,Section 30,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/311
PO.ET09.06. Novel Targets and Pathways,321,Section 29,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/321
PO.ET09.07. Kinase and Phosphatase Inhibitors 2,322,Section 25,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/322
PO.IM01.02. Immune Checkpoints and Inhibitory Molecules 1,333,Section 3,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/333
"PO.IM01.05. Inflammation, Host Factors, and Epigenetic Influences on Cancer Development and Treatment",335,Section 5,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/335
"PO.IM01.11. CAR-NK, NK Engagers, and NK Modulators",343,Section 2,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/343
PO.IM02.03. Inflammation and Cancer in Metastasis,354,Section 4,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/354
"PO.MCB01.02. Cell Cycle, DNA Repair, and Telomere Biology",361,Section 13,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/361
PO.MCB03.01. Cell Signaling Components as Therapeutic Targets,364,Section 14,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/364
PO.MCB06.01. Epigenetic Targets in Oncology,372,Section 16,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/372
PO.MCB07.02. Chromatin Organization and Regulators of Chromatin Biology,377,Section 15,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/377
PO.MCB08.02. Genomic Characterization of Cancers and Cancer Subgroups,382,Section 17,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/382
PO.MCB09.02. Metabolic Pathways 2,389,Section 18,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/389
PO.PR01.04. Health Disparities Across the Cancer Continuum,405,Section 31,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/405
"PO.PR02.01. Role of Diet, Nutrition, and the Microbiome Across the Cancer Continuum",407,Section 32,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/407
"PO.PS01.05. Diet, Alcohol, Tobacco Use, and Other Lifestyle Risk Factors",417,Section 33,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/417
PO.PS01.06. Survivorship Research,418,Section 34,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/418
PO.SHP01.01. Science and Health Policy,182,Section 1,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/182
"PO.TB02.01. Chemical, Environmental, and Virus-Induced Carcinogenesis",181,Section 7,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/181
PO.TB04.01. Metastasis Promoting and Suppressing Genes,425,Section 10,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/425
PO.TB04.05. Contributors to Metastatic Organotropism,430,Section 8,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/430
PO.TB05.01. Animal Models of Cancer,432,Section 6,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/432
PO.TB10.02. Tumor Evolution in Space and Time,447,Section 12,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/447
PO.TB11.07. Immune Cells in the Tumor Microenvironment 1,457,Section 9,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/457
PO.TB11.12. Pancreatic Cancer Microenvironment,462,Section 11,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/462
PO.BCS01.03. Application of Bioinformatics to Cancer Biology 3,190,Section 34,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/190
PO.BCS01.07. Artificial Intelligence and Machine/Deep Learning 2,194,Section 35,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/194
"PO.BCS01.09. Database Resources, Statistical Methods, and Other Tools",196,Section 36,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/196
PO.CH01.03. High-Throughput Screening and New Assay Technology,206,Section 20,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/206
PO.CL01.03. Circulating Tumor Cells 1,217,Section 42,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/217
PO.CL01.04. Metastasis Biomarkers,218,Section 45,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/218
PO.CL01.06. Biomarkers in Clinical Trials,220,Section 40,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/220
PO.CL01.14. Diagnostic Biomarkers 2,228,Section 44,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/228
PO.CL01.19. Circulating Nucleic Acids 3,233,Section 41,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/233
PO.CL06.01. Adoptive Cellular Therapy 1,238,Section 39,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/238
PO.CL06.04. Tumor Immune Response 2,242,Section 47,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/242
PO.CL06.12. Combination Immunotherapies,249,Section 43,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/249
PO.CL10.04. Outcome Investigation with Real World Data,263,Section 46,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/263
PO.CT01.01. First-in-Human Phase I Clinical Trials 1,610,Section 48,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/610
PO.CT01.03. Phase 0 and Phase I Clinical Trials,612,Section 49,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/612
PO.CTP01.02. Phase I Clinical Trials in Progress 2,620,Section 50,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/620
"PO.EN01.01. Molecular, Preclinical, and Clinical Endocrinology 1",269,Section 38,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/269
PO.ET01.03. Cancer Biology and Metastasis,274,Section 22,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/274
PO.ET02.01. Antibody-Drug Conjugates,281,Section 21,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/281
PO.ET02.03. Cancer Immunotherapy and Drug Delivery,283,Section 23,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/283
PO.ET03.02. Mechanisms of Drug Resistance 2,291,Section 26,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/291
PO.ET04.02. Immune Modulators and Antisense Molecules,298,Section 25,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/298
PO.ET06.03. Novel Therapeutics,306,Section 29,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/306
PO.ET09.02. Epigenetic Targets,317,Section 24,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/317
PO.ET09.04. Molecular Glues,319,Section 27,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/319
PO.ET09.08. Novel Antitumor Agents 3,323,Section 28,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/323
PO.IM01.03. Immune Checkpoints and Inhibitory Molecules 2,334,Section 4,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/334
PO.IM01.06. Single Target and Bispecific Antibodies,336,Section 6,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/336
PO.IM01.16. Antibody-Drug Conjugates,347,Section 2,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/347
PO.IM02.02. Epigenetic Regulation of Tumor Immunity,353,Section 3,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/353
PO.IM02.05. Innate Immunity in Cancer,356,Section 5,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/356
PO.MCB04.02. Cellular Stress Responses 2,368,Section 15,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/368
PO.MCB07.01. Oncogenic Transcription Factors,376,Section 18,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/376
"PO.MCB08.06. Advances in Genomic Sequencing Platforms, Methodologies, and Interpretation 2",386,Section 14,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/386
PO.MCB09.04. Signaling Pathways That Regulate Metabolism 1,391,Section 19,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/391
PO.MCB10.02. microRNA- and Other Non-coding RNA-Based Translational Medicine,395,Section 16,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/395
PO.MCB11.01. New Insights into Tumor Suppressor Genes,397,Section 17,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/397
PO.PR01.02. Cancer Control and Survivorship,402,Section 31,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/402
PO.PR02.03. Animal and Cellular Models of Cancer Prevention and the Study of Biological/Biochemical Mechanisms,411,Section 30,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/411
"PO.PS01.07. Biomarkers of Endogenous or Exogenous Exposures, Early Detection, Biologic Effects, and Prognosis",419,Section 32,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/419
"PO.PS01.11. Risk Prediction Modeling, Screening, Early Detection, and Preneoplastic and Tumor Markers",423,Section 33,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/423
PO.TB04.02. Biomarkers and Expression Differences in Metastatic Progression,426,Section 7,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/426
PO.TB05.02. Modeling Cancer in Mice,433,Section 10,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/433
PO.TB06.02. Pediatric Cancer Genomics and Epigenomics,441,Section 11,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/441
PO.TB07.01. Radiation Science,184,Section 12,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/184
PO.TB08.02. Cancer Stem Cells and Their Microenvironment,446,Section 8,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/446
PO.TB11.02. The Tumor Microenvironment as a Drug Target,451,Section 13,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/451
PO.TB11.10. Microbiome and Cancer,461,Section 9,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/461
PO.BCS01.04. Application of Bioinformatics to Cancer Biology 4,191,Section 35,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/191
PO.BCS01.08. Artificial Intelligence and Machine/Deep Learning 3,195,Section 36,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/195
PO.BCS01.10. Integrative Computational Approaches 1 / Analytic Pipeline Optimization,197,Section 37,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/197
PO.CH01.01. Targeted Protein Degradation,203,Section 21,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/203
PO.CH01.04. Drug Design and in Silico Screening,207,Section 20,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/207
PO.CL01.02. Prognostic Biomarkers 1,216,Section 46,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/216
PO.CL01.09. Predictive Biomarkers 3,222,Section 44,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/222
PO.CL01.11. Predictive Biomarkers 4,226,Section 45,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/226
PO.CL01.20. Circulating Nucleic Acids 4,235,Section 40,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/235
"PO.CL06.06. Chemotherapy, Radiation, and Vaccine Mediated Immunity",243,Section 39,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/243
"PO.CL07.02. Pediatric CNS Tumors, Leukemia, and Neuroblastoma: Translational",251,Section 43,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/251
PO.CL08.01. Novel Immunotherapies and Immune Modulation,255,Section 42,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/255
PO.CL10.03. Artificial Intelligence and Data Science on Real World Data,260,Section 38,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/260
PO.CL13.01. Molecular Biology in Clinical Oncology: Genetics and Beyond,265,Section 41,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/265
PO.CT01.02. First-in-Human Phase I Clinical Trials 2,611,Section 48,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/611
PO.CT02.01. Phase II Clinical Trials 1,615,Section 49,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/615
PO.CT03.01. Phase III Clinical Trials,618,Section 50,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/618
PO.ET01.04. Mechanisms of Drug Resistance and Novel Combinations,275,Section 25,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/275
PO.ET02.04. Drug Combinations,285,Section 23,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/285
"PO.ET02.10. New Targets, Technologies, and Drug Delivery Systems",545,Section 28,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/545
PO.ET03.05. Reversal of Drug Resistance 1,293,Section 30,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/293
PO.ET03.08. New Compounds and Drug Targets,295,Section 27,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/295
PO.ET05.03. Other Cellular Mechanisms for Anticancer Drug Action,299,Section 29,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/299
"PO.ET06.04. Molecular Classification of Tumors for Diagnostics, Prognostics, and Therapeutic Outcomes",309,Section 26,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/309
PO.ET09.01. DNA Reactive Agents,316,Section 22,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/316
PO.ET09.03. HDAC and Methyltransferase Inhibitors,318,Section 24,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/318
PO.IM01.04. Combination Approaches,338,Section 3,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/338
"PO.IM01.08. Vaccines, Antigens, and Antigen Presentation 1",339,Section 5,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/339
PO.IM01.15. Adoptive Cell Therapies 3: CAR-T Cells,346,Section 2,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/346
PO.IM01.19. Immune Modulation with Cytokines,351,Section 4,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/351
PO.IM02.01. Adaptive Immunity in Tumors,352,Section 1,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/352
PO.MCB02.02. Autophagy and Other Forms of Cell Death,362,Section 14,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/362
PO.MCB03.02. Deregulated Signaling in Tumor Development and Progression,365,Section 16,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/365
PO.MCB06.02. Epigenetics and Cancer Biology,373,Section 17,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/373
PO.MCB08.03. Characterization of Mutational Processes and Drivers in Cancer Development and Evolution,383,Section 15,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/383
PO.MCB09.03. Metabolomics,390,Section 18,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/390
PO.MCB09.05. Signaling Pathways That Regulate Metabolism 2,392,Section 19,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/392
PO.PR01.05. Population-Based Screening,404,Section 32,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/404
PO.PR02.04. Biomarkers and Molecular Targets for Cancer Prevention,409,Section 31,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/409
PO.PS01.03. Cancer Disparities 2: Survivorship Research Addressing Cancer Disparities,414,Section 33,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/414
PO.PS01.08. Descriptive Epidemiology and Statistical and Epidemiological Methodology,421,Section 34,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/421
PO.TB03.01. In Vivo Imaging and Anatomical and Molecular Pathology,183,Section 8,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/183
"PO.TB04.03. Detection, Treatment, and Prevention of Metastasis",427,Section 7,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/427
PO.TB05.03. In Vivo Imaging and Humanized Models,434,Section 9,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/434
PO.TB05.06. Organoid Models of Cancer 2,436,Section 11,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/436
PO.TB10.03. Tumor Evolution Models and Technologies,448,Section 13,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/448
PO.TB11.03. The Extracellular Matrix in Cancer,453,Section 12,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/453
PO.TB11.08. Models to Study Immune Cells in the Tumor Microenvironment,458,Section 10,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/458
PO.BCS01.11. Integrative Computational Approaches 2 / Sequence Analysis / Systems Engineering,546,Section 37,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/546
PO.BCS02.01. Integrative Cancer Science,199,Section 36,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/199
"PO.BCS02.02. Detection, Imaging, and Pathology",198,Section 35,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/198
PO.CH01.05. Drug Delivery,208,Section 20,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/208
PO.CH03.01. Structural and Chemical Biology,171,Section 21,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/171
PO.CL01.10. Predictive Biomarkers 5,224,Section 43,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/224
PO.CL01.12. Predictive Biomarkers 6,225,Section 44,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/225
PO.CL06.02. Adoptive Cellular Therapy 2,239,Section 40,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/239
PO.CL06.08. Antibodies 2,245,Section 41,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/245
PO.CL06.09. Tumor Microenvironment and Cancer Immunity,246,Section 47,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/246
PO.CL07.03. Pediatric Clinical Research and Late Effects,253,Section 42,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/253
PO.CL08.02. Targeting Kinase and ERK Pathways,254,Section 46,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/254
PO.CL10.02. Profiling Cancer with Real-World Evidence,261,Section 45,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/261
PO.CL12.02. Addressing Physical and Psychological Effects of Cancer Survivorship,264,Section 39,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/264
PO.CT02.02. Phase II Clinical Trials 2,616,Section 48,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/616
PO.CTP02.01. Phase II and Phase III Clinical Trials in Progress,622,Section 50,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/622
"PO.EN01.02. Molecular, Preclinical, and Clinical Endocrinology 2",270,Section 38,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/270
PO.ET01.05. Novel Biologic Therapies and Therapeutic Targets,276,Section 27,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/276
PO.ET02.05. Cancer Treatment: New Technologies,284,Section 22,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/284
PO.ET02.08. New Targets,288,Section 25,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/288
PO.ET03.03. Mechanisms of Drug Resistance 3,292,Section 24,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/292
PO.ET03.07. Drug Resistance 3: Regulation of Gene Expression,296,Section 23,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/296
PO.ET06.05. Novel Therapeutics and Preclinical Models,308,Section 28,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/308
"PO.ET08.02. Radiation, Theranostics, Radiotheranostics, Normal Tissue, and Cellular Stress",312,Section 29,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/312
PO.ET09.09. Novel Antitumor Agents 4,325,Section 26,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/325
PO.ET09.10. Targeted Protein Degraders,324,Section 30,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/324
PO.IM01.07. Immune Modulating Effects of Chemotherapy and Other Agents,337,Section 2,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/337
PO.IM01.12. Adoptive Cell Therapies 4,341,Section 1,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/341
PO.IM01.17. Immune Modulation Employing Agonist or Co-Stimulatory Approaches,349,Section 3,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/349
PO.IM02.04. Inflammation in Tumor Initiation and Progression,355,Section 4,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/355
PO.IM02.08. Tumor-Induced Immune Suppression 2: Intrinsic Factors,359,Section 5,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/359
PO.MCB01.01. Pharmacologic Targeting of Cell Cycle Proteins,360,Section 18,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/360
PO.MCB05.02. DNA Damage and Repair 2,370,Section 14,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/370
PO.MCB07.04. Gene Regulation and Transcriptional Profiles,379,Section 15,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/379
PO.MCB08.04. Genomic Changes and Intratumoral Heterogeneity as Predictive Biomarkers for Clinical Outcome,384,Section 16,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/384
PO.MCB10.03. microRNAs and Other Non-coding RNAs as Cancer Genes 2,396,Section 17,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/396
"PO.MCB11.02. Advances in Cancer Prognostication, Therapeutic Response, and Immune Biology",398,Section 13,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/398
PO.PR01.06. Biomarker-Based Screening,406,Section 31,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/406
"PO.PS01.01. Genetic Epidemiology 1: GxE, GWAS, and Next-Generation Sequencing",413,Section 33,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/413
PO.PS01.04. Cancer Disparities 3: Using Molecular Epidemiological Approaches to Decipher Cancer Disparities,416,Section 32,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/416
PO.TB01.01. Angiogenesis in Cancer,180,Section 6,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/180
PO.TB04.06. Invasion and Motility,429,Section 7,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/429
"PO.TB06.03. Pediatric Cancer Microenviroment, Tumor Heterogeneity, and Targeted Therapeutics",442,Section 9,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/442
PO.TB08.03. Mechanisms of Cancer Cell Stemness and Resistance,443,Section 8,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/443
PO.TB11.06. Tumor-Immune System Cross-Talk,456,Section 12,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/456
PO.TB11.11. Tumor Microenvironment of Metastasis,460,Section 11,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/460
PO.TB11.14. Spatial Resolution of the Tumor Microenvironment,464,Section 10,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/464
PO.BCS01.05. Application of Bioinformatics to Cancer Biology 5,192,Section 33,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/192
PO.BCS01.13. New Software Tools for Data Analysis,548,Section 35,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/548
PO.BCS02.03. Artificial Intelligence and Machine/Deep Learning 4,201,Section 34,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/201
PO.CH02.02. Proteomics and Mass Spectrometry 2,211,Section 20,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/211
PO.CL01.13. Predictive Biomarkers 7,227,Section 45,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/227
PO.CL01.21. Circulating Tumor Cells 2,234,Section 41,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/234
PO.CL01.22. Prognostic Biomarkers 2,236,Section 46,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/236
PO.CL06.03. Cancer Immunity and Inflammation,240,Section 40,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/240
PO.CL06.10. Immune Checkpoint Inhibitor Therapy,247,Section 42,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/247
PO.CL08.04. Other Targets,257,Section 44,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/257
PO.CL12.01. Biologic and Behavioral Effects of Cancer and Oncology Treatment,262,Section 39,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/262
PO.CL13.03. Molecular Biology in Clinical Oncology: Characterizing and Modulating Epigenetics and Gene Expression,267,Section 43,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/267
"PO.ET02.09. Targeted, Combination, and Differentiation Therapies",544,Section 26,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/544
PO.ET03.06. Reversal of Drug Resistance 2,297,Section 25,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/297
"PO.ET04.01. Vector Systems, Oncolytic Virotherapy, and Gene Therapy",303,Section 27,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/303
PO.ET06.02. DNA Damage and Repair,307,Section 22,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/307
PO.ET07.01. Pharmacology and Pharmacogenetics,310,Section 24,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/310
PO.ET09.11. YAP/TAZ/TEAD Modulators,326,Section 28,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/326
PO.ET09.12. Novel Antitumor Agents 6,327,Section 23,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/327
"PO.IM01.09. Vaccines, Antigens, and Antigen Presentation 2",340,Section 4,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/340
"PO.IM01.10. Immune Modulation by Viruses, Bacteria, Radiation, and Other Modalities",344,Section 1,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/344
PO.IM01.18. Targeted Immune Cell Engagers,348,Section 3,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/348
"PO.IM02.06. Microbiome, Inflammation, and Cancer",357,Section 2,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/357
PO.MCB03.03. Cancer Cell Communication with the Tumor Microenvironment,366,Section 13,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/366
PO.MCB06.03. Epigenetic Profiling and Technology,374,Section 15,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/374
PO.MCB07.03. Modifications and Signaling to Cancer Drivers,378,Section 18,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/378
PO.MCB08.05. Genomics and Immunooncology,385,Section 16,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/385
PO.MCB09.06. Mitochondrial Function 1,393,Section 17,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/393
PO.MCB11.03. Elucidating Mechanisms of Oncogenic Action,399,Section 14,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/399
PO.PR02.02. Secondary and Tertiary Cancer Prevention Studies and Patient Communication Decision Making,410,Section 30,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/410
"PO.PS01.09. Genetic Epidemiology 2: Family Studies, Pathway Analysis, and Functional Genetics",420,Section 31,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/420
PO.TB05.05. 3D and Tissue Recombinant Models of Cancer,439,Section 6,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/439
PO.TB05.07. Preclinical Studies of Cancer,440,Section 10,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/440
PO.TB10.01. Tumor Evolution at Single Cell Resolution,444,Section 11,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/444
PO.TB11.04. Chemokines and Cytokines in Cancer,454,Section 7,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/454
PO.TB11.09. Immune Cells in the Tumor Microenvironment 2,459,Section 9,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/459
PO.TB11.13. Gene Expression Regulation in the Tumor Microenvironment,463,Section 8,Poster Session,https://www.abstractsonline.com/pp8/#!/20272/session/463
APS02. Progress Since COVID-19 on Cancer Prevention Rates,127,Room 31 - Upper Level - Convention Center,Advances in Population Sciences,https://www.abstractsonline.com/pp8/#!/20272/session/127
APS01. Early-onset Cancers: Challenges and Opportunities for Prevention and Treatment,126,Room 14 - Mezzanine Level - Convention Center,Advances in Population Sciences,https://www.abstractsonline.com/pp8/#!/20272/session/126
APRV02. Current Tools and Approaches for Studying the Role of the Microbiome in Cancer Prevention,129,Room 31 - Upper Level - Convention Center,Advances in Prevention Research,https://www.abstractsonline.com/pp8/#!/20272/session/129
APRV01. From Precursors to Prevention: How Research into Cancer Precursor Lesions Creates Prevention Opportunities,128,Room 33 - Upper Level - Convention Center,Advances in Prevention Research,https://www.abstractsonline.com/pp8/#!/20272/session/128
APRV03. Application of Precision Medicine to Cancer Prevention,130,Room 29 - Upper Level - Convention Center,Advances in Prevention Research,https://www.abstractsonline.com/pp8/#!/20272/session/130
AT01. Unlocking Spatial Complexity: Harnessing Machine Learning for Spatial Biology Insights,63,Room 6 CF - Upper Level - Convention Center,Advances in Technologies,https://www.abstractsonline.com/pp8/#!/20272/session/63
AT06. Systematic Functional Approaches for Understanding and Targeting Cancer,68,Room 6 CF - Upper Level - Convention Center,Advances in Technologies,https://www.abstractsonline.com/pp8/#!/20272/session/68
AT05. Novel Experimental Models for Functional Precision Genomics,67,Ballroom 20 CD - Upper Level - Convention Center,Advances in Technologies,https://www.abstractsonline.com/pp8/#!/20272/session/67
AT03. Frontiers in Computational Oncology: Harnessing Multimodal Data for Biological Insight,65,Ballroom 20 CD - Upper Level - Convention Center,Advances in Technologies,https://www.abstractsonline.com/pp8/#!/20272/session/65
AT04. Mutational Processes in Cancer: From Replication Stress to Complex Genomic Rearrangements,66,Room 29 - Upper Level - Convention Center,Advances in Technologies,https://www.abstractsonline.com/pp8/#!/20272/session/66
AT02. Accelerating Precision Oncology through AI: Impact of Computational Pathology and Generative AI on Personalized Medicine,64,Room 30 - Upper Level - Convention Center,Advances in Technologies,https://www.abstractsonline.com/pp8/#!/20272/session/64
AT07. New Liquid Biopsy Technologies for Detection and Characterization of Cancer,69,Ballroom 20 CD - Upper Level - Convention Center,Advances in Technologies,https://www.abstractsonline.com/pp8/#!/20272/session/69
ASD01. Molecular Profiling in Breast Cancer and Racial/Ethnic Minorities: Dedicated to the Memory of Edith P. Mitchell,70,Room 31 - Upper Level - Convention Center,Advances in the Science of Cancer Disparities,https://www.abstractsonline.com/pp8/#!/20272/session/70
ASD02. Oncologic Anthropology: Impact of Genetic Ancestry and Social Determinants of Health on Breast Cancer Risk,71,Room 31 - Upper Level - Convention Center,Advances in the Science of Cancer Disparities,https://www.abstractsonline.com/pp8/#!/20272/session/71
REC01. AACR Annual Reception 2024,4,Seaport Ballroom - Manchester Grand Hyatt San Diego,Annual Reception,https://www.abstractsonline.com/pp8/#!/20272/session/4
LE03. AACR Award for Lifetime Achievement in Cancer Research,25,Ballroom 20 AB - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/25
LE19. Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research,41,Ballroom 20 CD - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/41
LE20. AACR-Irving Weinstein Foundation Distinguished Lectureship,42,Room 29 - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/42
LE07. AACR Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research,29,Room 31 - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/29
LE14. AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship,36,Room 33 - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/36
LE15. AACR-Princess Takamatsu Memorial Lectureship,37,Room 6 DE - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/37
LE22. AACR Distinguished Public Service Award for Lifetime Achievement in Cancer Research,670,Room 33 - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/670
LE13. AACR-Joseph H. Burchenal Award for Outstanding Achievement in Clinical Cancer Research,35,Room 6 DE - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/35
LE17. AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research,39,Room 31 - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/39
LE01. Presidential Address:&nbsp;Engineering T Cells to Eradicate Tumors - Identifying and Overcoming the Obstacles,2,Ballroom 20 CD - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/2
LE02. NCI Director's Address and Fireside Chat,3,Ballroom 6 A - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/3
LE18. AACR-Women in Cancer Research Charlotte Friend Lectureship,40,Room 17 - Mezzanine Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/40
LE09. AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research,31,Ballroom 20 AB - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/31
LE06. AACR Award for Outstanding Achievement in Chemistry in Cancer Research,28,Room 28 - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/28
LE11. AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology,33,Ballroom 6 A - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/33
LE04. AACR Award for Outstanding Achievement in Basic Cancer Research,26,Room 14 - Mezzanine Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/26
LE12. AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research,34,Room 17 - Mezzanine Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/34
LE21. AACR Gertrude B. Elion Cancer Research Award Lecture: Mechanisms of Gene Regulation by Chromatin Adaptors in Development and Disease,564,Room 5 - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/564
LE10.  AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention,32,Room 29 - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/32
LE16. AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research,38,Room 16 - Mezzanine Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/38
LE08. AACR James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research,30,Room 15 - Mezzanine Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/30
LE05. AACR Award for Outstanding Achievement in Blood Cancer Research,27,Room 29 - Upper Level - Convention Center,Awards and Lectures,https://www.abstractsonline.com/pp8/#!/20272/session/27
CF01. AACR Cancer and Biomedical Research Career Fair,59,Hall F - Ground Level - Convention Center,Cancer and Biomedical Research Career Fair,https://www.abstractsonline.com/pp8/#!/20272/session/59
FO03. Financial Hardship following Cancer Diagnosis: Opportunities for Improving Care and Patient Outcomes,77,Room 31 - Upper Level - Convention Center,Forum,https://www.abstractsonline.com/pp8/#!/20272/session/77
FO05. Optimizing Cancer Care in Low Resource Settings,79,Room 33 - Upper Level - Convention Center,Forum,https://www.abstractsonline.com/pp8/#!/20272/session/79
FO07. Breaking the Obesity-Cancer Link: The Role of New Weight Loss Drugs,81,Room 30 - Upper Level - Convention Center,Forum,https://www.abstractsonline.com/pp8/#!/20272/session/81
FO08. Optimizing Cancer Vaccines through Advances in Immunogenomics and Immunopeptidomics,82,Hall GH - Ground Level - Convention Center,Forum,https://www.abstractsonline.com/pp8/#!/20272/session/82
FO01. Opportunities and Challenges in Leveraging Real-World Data to Accelerate Evidence Generation,72,Room 6 CF - Upper Level - Convention Center,Forum,https://www.abstractsonline.com/pp8/#!/20272/session/72
FO02. Using Small-Molecule Inhibitors in Cancer Research and Drug Discovery: How Can We Maximize Their Value?,75,Room 30 - Upper Level - Convention Center,Forum,https://www.abstractsonline.com/pp8/#!/20272/session/75
FO04. Can Trust in Science Help Us Decrease Cancer Health Care Disparities and Increase Clinical Trials&nbsp;Participation? &nbsp;,78,Room 33 - Upper Level - Convention Center,Forum,https://www.abstractsonline.com/pp8/#!/20272/session/78
"FO06. Lifestyle Choices, the Food Environment, and Health Equity Impact Cancer Prevention and Control - But Are There Solutions? And What Are the Opportunities for Future Research?",80,Ballroom 6 B - Upper Level - Convention Center,Forum,https://www.abstractsonline.com/pp8/#!/20272/session/80
FO09. Mechanisms of Resistance: Why Have We Failed to Turn Cold Tumors Hot?,83,Ballroom 6 A - Upper Level - Convention Center,Forum,https://www.abstractsonline.com/pp8/#!/20272/session/83
DC10. Perioperative Pandemonium: Trial Designs in Solid Tumors,53,Room 1 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/53
SY03. Epigenetics and Chromatin Regulation in Cancer,87,Ballroom 6 B - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/87
SY10. Approaches to Improve Quality of Life and Long-term Outcomes in Cancer Survivors Across the Lifespan,96,Room 11 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/96
SY15. Socioeconomic Contributions to Cancer Health Disparities,102,Room 14 - Mezzanine Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/102
SY19. Targeting Cyclin-CDKs in Cancer: The Cell Cycle Beyond CDK4/6,133,Room 33 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/133
"SY31. Neuronal Signaling, Unlocking a New Hallmark of Cancer",145,Room 5 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/145
SY37. Eavesdropping on the Immunosuppressive Crosstalk between the Myeloid and T Cell Compartments,151,Ballroom 6 A - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/151
SY40. Immunometabolism,154,Ballroom 20 AB - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/154
DC15. Patient Advocate Poster Symposium,58,Location to be announced,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/58
DC03. FDA Center for Tobacco Products&rsquo; Priorities to Reduce Tobacco Use and Support the Cancer Moonshot,46,Room 5 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/46
"DC04. Trading Places: Regulator as Patient, Patient as Regulator",47,Room 1 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/47
SY01. Presidential Select Symposium: Cancer Immunotherapy - Where Do We Go From Here?,13,Hall GH - Ground Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/13
SY02. Understanding and Predicting Tumor Evolution,86,Ballroom 6 B - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/86
SY05. Chromatin and Cancer: From Mechanisms to Therapy,89,Room 28 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/89
SY11. RNA Modifications in Malignancy,97,Room 29 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/97
SY22. Targeting the Mitotic Cell Cycle: Emerging Strategies,136,Room 33 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/136
"SY25. Advances in Pediatric Cancer: Mechanisms, Vulnerabilities, and Translation",139,Room 6 DE - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/139
SY30. Radiation Induced Tumor Metabolic Rewiring Modulates Therapeutic Responses,144,Room 17 - Mezzanine Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/144
"SY33. AACR-Bayard D. Clarkson Symposium: Cellular Plasticity in Tumor Development, Metastasis and Response to Therapy",147,Ballroom 6 A - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/147
SY38. The Growing Impact of Obesity on Cancer and Cancer Immunotherapy Outcomes,152,Room 30 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/152
SY47. Surgical Innovations in Breast Cancer,119,Room 11 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/119
DC05. Disparities in Pediatric Oncology,48,Room 1 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/48
SY06. Cancer Epigenome Analysis for Novel Diagnostic Markers and Therapeutic Strategies,90,Ballroom 20 AB - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/90
SY24. Neoadjuvant Therapies,138,Ballroom 6 B - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/138
SY27. Targeting Aberrant Transcription in Pediatric Cancer,141,Room 33 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/141
"SY28. Addressing Shared Risk Factors for Cancer, Cardiovascular Disease and Metabolic Disease",142,Room 28 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/142
SY36. Somatic Evolution in Normal Tissues: Causes and Consequences - Dedicated to the Memory of Judith Campisi,150,Room 6 CF - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/150
SY43. New Models of CAR-T Cells,157,Hall GH - Ground Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/157
SY46. Communication between DNA Damage and Immune Responses in Cancer,160,Room 6 DE - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/160
DC09. In the Eye of the Beholder: Equipoise in Cancer Clinical Trials,52,Room 1 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/52
"DC07. Diversity Plans in Action: FDA, Industry, and Community Perspectives",50,Room 1 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/50
"SY08. Health Behavior Practices after Cancer Diagnosis to Deter Cancer Progression and Death - Evidence, Gaps, and Solutions&nbsp;",93,Room 6 DE - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/93
"SY12. Molecular Glues, PROTACs, and Next-Gen Degraders: Discovery and Early Preclinical Advances",99,Room 31 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/99
SY17. The Microbiome and Treatment Response to Cancer Therapy,131,Room 16 - Mezzanine Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/131
SY21. Harnessing Altered Metabolism for Novel Cancer Therapies,135,Ballroom 6 B - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/135
SY23. Biomarkers in the Post-TCGA Era: Where Are We Now?,137,Ballroom 6 A - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/137
SY32. Crosstalk within the Tumor Ecosystem,146,Room 30 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/146
SY41. Antigen Discovery and Validation for Cancer Vaccines,155,Room 33 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/155
SY44. Dharma Master Jiantai Symposium in Targeted Therapy: T Cell-based Therapies for Solid Tumors,158,Ballroom 20 AB - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/158
DC08. Putting the Precision Back in Precision Oncology,51,Room 1 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/51
SY20. CDK4/6 Inhibitors: Not Just for Breast Cancer Anymore,134,Room 6 DE - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/134
SY26. Advancing Cellular Therapies for Childhood Solid Malignancies: Dedicated to the Memory of Sharon B. Murphy,140,Ballroom 6 B - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/140
SY34. Cancer Dormancy: From Basic Biology to Clinical Reality,148,Room 28 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/148
SY42. Discovering and Broadening the Therapeutic Modalities of Immune Therapy,156,Hall GH - Ground Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/156
DC14. The Cancer Moonshot: Challenges to Fulfilling the Vision of the National Cancer Plan - Dedicated to the Memory of Senator Dianne Feinstein,57,Room 1 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/57
SY04. Genomic Instability and Metastasis: Dangerous Liaisons or Two Sides of the Same Coin?,88,Room 30 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/88
SY07. Cellular Competition in Premalignancy and Cancer,91,Room 31 - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/91
SY09. Interventional Studies during Cancer Treatment to Improve Symptoms and Outcomes,95,Room 16 - Mezzanine Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/95
SY13. Emerging Induced Proximity Therapeutic Modalities,100,Room 6 DE - Upper Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/100
SY16. Biology and Treatment Strategies for IDH-mutant Cancers,103,Room 17 - Mezzanine Level - Convention Center,Major Symposium,https://www.abstractsonline.com/pp8/#!/20272/session/103
"MG04. Meet the Editors-in-Chief of Cancer Discovery: Lewis C. Cantley, PhD and Luis A. Diaz Jr., MD",640,AACR Publications Booth 4043 - Hall AF,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/640
"MG05. Meet the Editor-in-Chief of Cancer Epidemiology, Biomarkers & Prevention: Elizabeth A. Platz, ScD, MPH",641,AACR Publications Booth 4043 - Hall AF,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/641
"MG06. Meet the Editor-in-Chief of Cancer Research: Christine Iacobuzio-Donahue, MD, PhD",642,AACR Publications Booth 4043 - Hall AF,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/642
MG02. AACR Associate Member Meet and Greet,561,Grand Hall B - Manchester Grand Hyatt San Diego ,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/561
"MG07. Meet the Editors-in-Chief of Cancer Immunology Research: Robert D. Schreiber, PhD and Philip D. Greenberg, MD",643,AACR Publications Booth 4043 - Hall AF,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/643
"MG08. Meet the Editor-in-Chief of Molecular Cancer Research: Massimo Loda, MD",644,AACR Publications Booth 4043 - Hall AF,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/644
"MG09. Meet the Editors-in-Chief of Blood Cancer Discovery: Riccardo Dalla-Favera, MD and Kenneth C. Anderson, MD",645,AACR Publications Booth 4043 - Hall AF,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/645
"MG03. Meet the Editor-in-Chief of Clinical Cancer Research: Keith T. Flaherty, MD",639,AACR Publications Booth 4043 - Hall AF,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/639
MG13. Meet the Research Grant Reviewers,668,Room 26 - Upper Level - Convention Center,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/668
"MG10. Meet the Editor-in-Chief of Molecular Cancer Therapeutics:  Beverly A. Teicher, PhD",646,AACR Publications Booth 4043 - Hall AF,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/646
"MG11. Meet the Editors-in-Chief of Cancer Prevention Research: Raymond N. DuBois, MD, PhD and Nickolas Papadopoulos, PhD",647,AACR Publications Booth 4043 - Hall AF,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/647
"MG12. Meet the Editors-in-Chief of Cancer Research Communications: Elaine R. Mardis, PhD and Lillian L. Siu, MD",648,AACR Publications Booth 4043 - Hall AF,Meet and Greet,https://www.abstractsonline.com/pp8/#!/20272/session/648
MW01. A Preview into Single-cell Data Analysis for Bench-based Scientists,501,Ballroom 6 A - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/501
"MW06. Clinical Trial Design Workshop, Part 1: Increasing Racial and Ethnic Diversity in Clinical Trials: New Solutions for Old Problems",496,Room 6 CF - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/496
MW11. Characterizing Complex Structural Variation and 3D Genome Architecture,491,Room 30 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/491
MW13. How Can We Improve the Quality of Research with Antibody Reagents in Cancer Research?,477,Room 6 DE - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/477
"MW04. Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 1 - Design and Implementation of Novel Phase 1 and 2 Clinical Trials ",498,Room 29 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/498
MW19. Analytic Resources and Applications for AACR Project GENIE BPC Clinico-genomic Data,465,Room 28 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/465
"MW05. Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 2 - Designing Pivotal Phase 3 Trials for Regulatory Approval of New Agents or New Indications ",497,Room 29 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/497
MW16. Pathology for Cancer Researchers,471,Room 33 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/471
MW17. Innovative Software Analytics for Pediatric Cancer Clinical Testing,469,Room 31 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/469
MW18. Lineage Tracing in Cancer,466,Room 28 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/466
MW09. Emerging Data Analysis Methods for Cancer Research,493,Ballroom 20 CD - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/493
MW10. Implementing/Applying Technologies to Build Capacity in Low- and Middle-income Countries,492,Room 28 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/492
MW14. Choosing and Using Antibodies for Spatial Informed Protein Expression,475,Room 11 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/475
MW15. Choosing the Right Animal Model for Your Study,472,Room 30 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/472
"MW08. Clinical Trial Design Workshop, Part 2: Precision Combination Therapy",494,Room 30 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/494
MW12. Functional Variomics and Network Approaches in Cancer Research,478,Room 28 - Upper Level - Convention Center,Methods Workshop,https://www.abstractsonline.com/pp8/#!/20272/session/478
"MS.BCS01.02. Algorithms, Platforms, and Emerging Concepts",187,Room 14 - Mezzanine Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/187
MS.CL01.03. Biomarkers Predictive of Therapeutic Benefit,214,Room 6 CF - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/214
MS.ET01.01. Biological Therapeutic Agents,271,Room 15 - Mezzanine Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/271
MS.ET03.01. Concurring Drug Resistance by Innovative Research,289,Ballroom 6 B - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/289
MS.ET09.01. Novel Antitumor Agents 1,315,Room 11 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/315
MS.IM01.03. Tumor-Targeted Immune Cell Engagers,331,Room 30 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/331
MS.MCB06.01. Cancer Epigenetics,371,Ballroom 6 A - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/371
MS.MD01.01. Advancing Cancer Research Through an International Cancer Registry: AACR Project GENIE Use Cases,177,Room 5 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/177
MS.MD01.02. Genetic and Cellular Mediators of Tumor Progression,551,Room 17 - Mezzanine Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/551
MS.PR01.01. Multi-Cancer Early Detection Testing:  Where Are We?,400,Room 28 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/400
MS.TB04.01. Metastasis,424,Room 29 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/424
MS.TB11.01. Microbes and Tumors: Time for Mechanisms,449,Room 16 - Mezzanine Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/449
MS.BCS01.01. Multi-omic Analysis and Translational Research,188,Ballroom 20 AB - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/188
"MS.CH01.01. Identification, Optimization, and Characterization of Protein Degraders and Inhibitors",204,Room 11 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/204
MS.CL01.02. Early Detection and Progression Biomarkers,213,Ballroom 6 B - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/213
MS.CL10.01. Application of Real-World Evidence to Cancer Care,259,Room 6 CF - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/259
MS.ET02.02. Drug Discovery 1: New Targets and Approaches,280,Room 30 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/280
MS.ET06.01. Novel Molecular Targets and Biomarkers,304,Room 6 DE - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/304
MS.IM01.02. Immune Targets and Therapies,330,Ballroom 20 CD - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/330
MS.IM02.01. Understanding and Targeting Pathogenic Inflammation in Solid Tumors,350,Room 28 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/350
MS.MCB03.01. Novel Mechanisms of Oncogenesis and New Therapeutic Targets,363,Room 33 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/363
"MS.MCB08.01. Advances in Cancer Genomics: Carcinogenesis, Tumor Evolution, and Heterogeneity",380,Room 31 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/380
MS.PS01.02. Cancer Disparities Research,412,Room 14 - Mezzanine Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/412
MS.TB06.01. Genetic Drivers and Therapeutic Achilles' Heels of Childhood Cancers,437,Room 15 - Mezzanine Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/437
MS.BCS02.01. Computational Approaches to Precision Medicine,200,Ballroom 20 AB - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/200
MS.CL01.01. Liquid Biopsy,212,Room 6 CF - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/212
MS.CL06.01. Immuno-oncology,237,Ballroom 20 CD - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/237
MS.CL08.01. Novel Approaches for Targeted Therapies,252,Ballroom 6 A - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/252
"MS.EN01.01. Molecular, Preclinical, and Clinical Endocrinology 3",268,Room 5 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/268
MS.ET02.01. Drug Discovery 2: New Therapies,279,Room 30 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/279
MS.ET09.02. Novel Antitumor Agents 5,313,Room 6 DE - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/313
MS.IM01.01. New Insights for Therapies Modulating Antitumor T-Cell Responses,329,Ballroom 6 B - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/329
MS.MCB07.01. Chromatin and Transcriptional Regulatory Mechanisms in Cancer,375,Room 31 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/375
MS.MCB09.01. Metabolism and Cancer,387,Room 28 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/387
MS.PS01.01. Molecular Epidemiology,408,Room 11 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/408
MS.TB05.01. Nonclinical Models of Cancer,431,Room 33 - Upper Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/431
MS.TB11.02. The Microenvironment: Beyond Surrounding the Tumor,450,Room 14 - Mezzanine Level - Convention Center,Minisymposium,https://www.abstractsonline.com/pp8/#!/20272/session/450
NIH01. Year of Open Science: Impact of the Cancer Research Data Commons (CRDC),626,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/626
"NIH02: . Early-Onset Cancers from Etiology to Survivorship: Funding Opportunities, Resources, and Future Research Needs",627,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/627
NIH03. Cancer Health Disparities Research Collaborations Across CRCHD and DCB,628,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/628
NIH04. NCI Funding Opportunities in Cancer Prevention and Interception,629,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/629
NIH05. Review and Funding of Foundational Cancer Biology Research at NIH & NCI,630,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/630
NIH06. NCI Funding Opportunities and Grant Writing Strategies for New and Early-Stage Investigators,631,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/631
NIH07. From Lab to Market:  Funding and Transition Support for Early-Stage Oncology Startups from National Cancer Institute,632,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/632
NIH08. NCI Network: Participant Engagement and Cancer Genome Sequencing (PE-CGS) Community Health Educator Supplement Program,633,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/633
NIH09. Intramural and Extramural Training and Career Development Awards and Opportunities,634,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/634
NIH10. Building on the Power of Data and Community,635,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/635
"NIH11. NCI Division of Cancer Prevention Research Resources, Funding Opportunities, and Research Workforce Activities",636,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/636
NIH12. NCI Artificial Intelligence (AI) Programs and Resources for Advancing Cancer Research,637,Room 2 - Upper Level - Convention Center,NCI-NIH-Sponsored Session,https://www.abstractsonline.com/pp8/#!/20272/session/637
PL01. Discovery Science in Early Cancer Biology and Interception,6,Hall GH - Ground Level - Convention Center,Plenary Session,https://www.abstractsonline.com/pp8/#!/20272/session/6
"PL02. Opening Plenary Session: Inspiring Science, Fueling Progress, Revolutionizing Care",7,Hall GH - Ground Level - Convention Center,Plenary Session,https://www.abstractsonline.com/pp8/#!/20272/session/7
PL03. Profiling Tumor Ecosystems in Native Tissue Context,8,Hall GH - Ground Level - Convention Center,Plenary Session,https://www.abstractsonline.com/pp8/#!/20272/session/8
"PL04. Evolution of the Genome, Microenvironment, and Host through Metastasis",9,Hall GH - Ground Level - Convention Center,Plenary Session,https://www.abstractsonline.com/pp8/#!/20272/session/9
"PL05. AI at the Interface: Accelerating Evidence Generation, Advancing Disparities Research, and Improving Trial Design",10,Ballroom 20 - Upper Level - Convention Center,Plenary Session,https://www.abstractsonline.com/pp8/#!/20272/session/10
PL06. AACR Annual Meeting 2024 Highlights: Vision for the Future,11,Ballroom 20 - Upper Level - Convention Center,Plenary Session,https://www.abstractsonline.com/pp8/#!/20272/session/11
PAS01. Grant Writing Workshop: Tips for Success from Experienced Scientist,162,Location to be announced,Professional Advancement Session,https://www.abstractsonline.com/pp8/#!/20272/session/162
PAS02. How To Design a Successful Career Path In Cancer Research: The Do&rsquo;s And Don&rsquo;ts For Early-Stage Investigators,163,Location to be announced,Professional Advancement Session,https://www.abstractsonline.com/pp8/#!/20272/session/163
PAS03. Personalized Career Conversations,164,Location to be announced,Professional Advancement Session,https://www.abstractsonline.com/pp8/#!/20272/session/164
PAS06. Productive Peer Review: Improving Science While Avoiding Common Pitfalls,559,Grand Ballroom C - Omni San Diego Hotel,Professional Advancement Session,https://www.abstractsonline.com/pp8/#!/20272/session/559
PAS04. Navigating The Path to a Successful Career in Cancer Research,165,Location to be announced,Professional Advancement Session,https://www.abstractsonline.com/pp8/#!/20272/session/165
PAS05. Building an Effective Mentorship Team: Essential Strategies at Every Stage in Your Career,166,Location to be announced,Professional Advancement Session,https://www.abstractsonline.com/pp8/#!/20272/session/166
SS05. Strategies to Effectively Communicate Science to the Public,557,Ballroom 6 A - Upper Level - Convention Center,Special Session,https://www.abstractsonline.com/pp8/#!/20272/session/557
DDT01. New Drugs on the Horizon: Part 1,552,Ballroom 20 CD - Upper Level - Convention Center,Special Session,https://www.abstractsonline.com/pp8/#!/20272/session/552
DDT02. New Drugs on the Horizon: Part 2,553,Ballroom 20 CD - Upper Level - Convention Center,Special Session,https://www.abstractsonline.com/pp8/#!/20272/session/553
DDT03. New Drugs on the Horizon: Part 3,554,Ballroom 20 CD - Upper Level - Convention Center,Special Session,https://www.abstractsonline.com/pp8/#!/20272/session/554
SS06. AACR Annual Business Meeting of Members,667,Room 5 - Upper Level - Convention Center,Special Session,https://www.abstractsonline.com/pp8/#!/20272/session/667
SS07. Convergence Research: Deciphering Tumor Microenvironment Interactions and Therapeutic Responses with Cutting-Edge Multi-Organ Organoids and Multi-Omics: A SU2C Session,669,Room 30 - Upper Level - Convention Center,Special Session,https://www.abstractsonline.com/pp8/#!/20272/session/669
SS03. AACR-JCA Joint Session: Novel Molecular Drivers of Gastroesophageal Cancers and Evolving Biomarker Driven Therapies,24,Room 29 - Upper Level - Convention Center,Special Session,https://www.abstractsonline.com/pp8/#!/20272/session/24
SS02. AACR-ASCO Joint Session: Strategies for Detecting Minimal Residual Disease (MRD) and How to Apply It in the Clinic,23,Room 6 DE - Upper Level - Convention Center,Special Session,https://www.abstractsonline.com/pp8/#!/20272/session/23
SS04. The Nature of Cancer: Lessons Learned from Tumors with Simple Genomes &nbsp; &nbsp; &nbsp;,161,Ballroom 20 CD - Upper Level - Convention Center,Special Session,https://www.abstractsonline.com/pp8/#!/20272/session/161
TM02. Crosstalk of Immune Cells and Metabolic Pathways in the Tumor-Immune Microenvironment: A Cancer Immunology Working Group Town Hall,15,Sapphire Ballroom - Hilton Bayfront Hotel,Town Meeting,https://www.abstractsonline.com/pp8/#!/20272/session/15
TM05. Then and Now: Updates in Pediatric Cancer Predisposition&mdash; A Pediatric Cancer Working Group Town Hall Meeting,18,Sapphire Ballroom - Hilton Bayfront Hotel,Town Meeting,https://www.abstractsonline.com/pp8/#!/20272/session/18
TM06. Artificial Intelligence for Research Enhancement in Population Sciences: A Population Sciences Working Group Town Hall Meeting,19,Sapphire Ballroom - Hilton Bayfront Hotel,Town Meeting,https://www.abstractsonline.com/pp8/#!/20272/session/19
TM03. Perspectives in Cancer Prevention: Global and Early Detection Approaches: A Cancer Prevention Working Group Town Hall - Dedicated to the Memory of David S. Alberts,16,Sapphire Ballroom - Hilton Bayfront Hotel,Town Meeting,https://www.abstractsonline.com/pp8/#!/20272/session/16
TM04. Losing our inhibitions &ndash; is (protein) degradation preferred?: A Chemistry in Cancer Research Working Group Town Hall Meeting,17,Sapphire Ballroom - Hilton Bayfront Hotel,Town Meeting,https://www.abstractsonline.com/pp8/#!/20272/session/17
TM01. Is Cancer Evolution Key to Understanding and Strategically Applying the Multiple Cancer Early Detection (MECED) Assays?: A Cancer Evolution Working Group Town Hall Meeting,14,Sapphire Ballroom - Hilton Bayfront Hotel,Town Meeting,https://www.abstractsonline.com/pp8/#!/20272/session/14
"TM07. Language Models, Processing, and Deep Learning in Radiation Oncology, the New Frontier: A Radiation Science and Medicine Working Group Town Hall Meeting",20,Sapphire Ballroom - Hilton Bayfront Hotel,Town Meeting,https://www.abstractsonline.com/pp8/#!/20272/session/20
TM08. Targeting the Tumor Microenvironment for the Benefit of Cancer Patients: A Tumor Microenvironment Working Group Town Hall,21,Sapphire Ballroom - Hilton Bayfront Hotel,Town Meeting,https://www.abstractsonline.com/pp8/#!/20272/session/21
